Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04092647Phase 2Unknown
Ashwagandha for Cognitive Dysfunction
Chemo Fog
PrincipalinvestigatorStart date: 2023-01-01

Research Network

Collaboration Network

4 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Sutter Health

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Grigore C Burdea, PhD

Bright Cloud Int'l Corp

Moderately Similar
2 trials

Shared therapeutic areas:

Chemotherapy-Related Cognitive Impairment
Similarity Score30%

Betülay Kılıç, Doçent Doktor

Health Sciences University Gulhane Faculty of Nursing

Moderately Similar
1 trials

Shared therapeutic areas:

Chemotherapy-Related Cognitive Impairment
Similarity Score30%

Gizem Erdoğan, Hemşire

Health Sciences University Gulhane Training and Research Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Chemotherapy-Related Cognitive Impairment
Similarity Score30%

Paul A Newhouse, MD

Vanderbilt University Medical Center

Moderately Similar
3 trials

Shared therapeutic areas:

Chemotherapy-Related Cognitive Impairment
Similarity Score30%

Robert J Ferguson, PhD

St. Jude Children's Research Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

Chemotherapy-Related Cognitive Impairment
Similarity Score30%

Donna Posluszny, PhD

University of Pittsburgh

Moderately Similar
2 trials

Shared therapeutic areas:

Chemotherapy-Related Cognitive Impairment
Similarity Score30%

Debbie Anglade, PhD, MSN, RN

University of Miami

Moderately Similar
1 trials

Shared therapeutic areas:

Chemotherapy-Related Cognitive Impairment
Similarity Score30%

Joseph McCollom, DO

Parkview Health

Moderately Similar
1 trials

Shared therapeutic areas:

Chemotherapy-Related Cognitive Impairment
Similarity Score30%

Paul A Newhouse, M.D.

Vanderbilt University

Moderately Similar
2 trials

Shared therapeutic areas:

Chemotherapy-Related Cognitive Impairment
Similarity Score30%

Shiyan Yan, PhD

Beijing University of Chinese Medicine

Moderately Similar
1 trials

Shared therapeutic areas:

Chemotherapy-Related Cognitive Impairment
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04092647Phase 2PrincipalInvestigator

Ashwagandha for Cognitive Dysfunction

Chemo Fog
Unknown

All 1 trials loaded